Examining the genetic and neural components of cognitive flexibility using mice

Physiology and Behavior

Volumn 107, Issue 5, 2012, Pages 666-669

  Brigman, Jonathan L ^a   Powell, Elizabeth M ^b   Mittleman, Guy ^c   Young, Jared W ^d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of Memphis   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Executive functioning; In vivo electrophysiology; Learning; Mouse; Reversal learning

Indexed keywords

NICOTINIC RECEPTOR; PARVALBUMIN; PROTEIN C FOS;

ARTICLE; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; CELL LOSS; CEREBELLUM; COGNITIVE DEFECT; ELECTROCHEMICAL ANALYSIS; EXECUTIVE FUNCTION; GABAERGIC SYSTEM; GENETIC MANIPULATION; GENETIC VARIABILITY; IN VITRO STUDY; IN VIVO STUDY; INTERNEURON; KNOCKOUT MOUSE; LEARNING; MENTAL DISEASE; MOTIVATION; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; WORKING MEMORY;

ANIMALS; COGNITION; CORPUS STRIATUM; EXECUTIVE FUNCTION; LEARNING; MICE; NEURAL PATHWAYS; NEURONAL PLASTICITY; RECEPTORS, NICOTINIC;

EID: 84871120165     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.12.024     Document Type: Article

References (41)

1. Barch D.M., Carter C.S., Arnsten A., Buchanan R.W., Cohen J.D., Geyer M., et al. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 2009, 35:109-114.
2. Buchanan R.W., Freedman R., Javitt D.C., Abi-Dargham A., Lieberman J.A. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 2007, 33:1120-1130.
3. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006, 67(Suppl. 9):3-8. discussion 36-42.
4. Brigman J.L., Graybeal C., Holmes A. Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia. Front Neurosci 2010, 4.
5. Barch D.M., Braver T.S., Carter C.S., Poldrack R.A., Robbins T.W. CNTRICS final task selection: executive control. Schizophr Bull 2009, 35:115-135.
6. Floresco S.B., Jentsch J.D. Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 2011, 36:227-250.
7. Floresco S.B., Geyer M.A., Gold L.H., Grace A.A. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr Bull 2005, 31:888-894.
8. Young J.W., Light G.A., Marston H.M., Sharp R., Geyer M.A. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One 2009, 4:e4227.
9. Young J.W., Powell S.B., Geyer M.A. Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology 2011, [Electronic publication ahead of print].
10. Chudasama Y., Baunez C., Robbins T.W. Functional disconnection of the medial prefrontal cortex and subthalamic nucleus in attentional performance: evidence for corticosubthalamic interaction. J Neurosci 2003, 23:5477-5485.
11. Featherstone R.E., McDonald R.J. Dorsal striatum and stimulus-response learning: lesions of the dorsolateral, but not dorsomedial, striatum impair acquisition of a simple discrimination task. Behav Brain Res 2004, 150:15-23.
12. Brigman J.L., Mathur P., Harvey-White J., Izquierdo A., Saksida L.M., Bussey T.J., et al. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex 2010, 20(8):1955-1963.
13. Schoenbaum G., Nugent S.L., Saddoris M.P., Setlow B. Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport 2002, 13:885-890.
14. Yin H.H., Knowlton B.J., Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci 2004, 19:181-189.
15. Brigman J.L., Wright T., Talani G., Prasad-Mulcare S., Jinde S., Seabold G.K., et al. Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 2010, 30:4590-4600.
16. Partridge J.G., Tang K.C., Lovinger D.M. Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 2000, 84:1422-1429.
17. Yin H.H., Mulcare S.P., Hilario M.R., Clouse E., Holloway T., Davis M.I., et al. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 2009, 12:333-341.
18. Dickson P.E., Rogers T.D., Del Mar N., Martin L.A., Heck D., Blaha C.D., et al. Behavioral flexibility in a mouse model of developmental cerebellar Purkinje cell loss. Neurobiol Learn Mem 2010, 94:220-228.
19. Martin L.A., Goldowitz D., Mittleman G. Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism. Eur J Neurosci 2010, 31:544-555.
20. Martin L.A., Goldowitz D., Mittleman G. The cerebellum and spatial ability: dissection of motor and cognitive components with a mouse model system. Eur J Neurosci 2003, 18:2002-2010.
21. Martin L.A., Goldowitz D., Mittleman G. Sustained attention in the mouse: a study of the relationship with the cerebellum. Behav Neurosci 2006, 120:477-481.
22. Mittleman G., Goldowitz D., Heck D.H., Blaha C.D. Cerebellar modulation of frontal cortex dopamine efflux in mice: relevance to autism and schizophrenia. Synapse 2008, 62:544-550.
23. Wonders C.P., Anderson S.A. The origin and specification of cortical interneurons. Nat Rev Neurosci 2006, 7:687-696.
24. Campbell D.B., D'Oronzio R., Garbett K., Ebert P.J., Mirnics K., Levitt P., et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007, 62:243-250.
25. Powell E.M., Campbell D.B., Stanwood G.D., C., D., Noebels J.L., Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003, 23:622-631.
26. Bissonette G.B., Bae M.H., Suresh T., Jaffe D.E., Powell E.M. Astrocyte-mediated hepatocyte growth factor/scatter factor supplementation restores GABAergic interneurons and corrects reversal learning deficits in mice. J Neurosci 2010, 30:2918-2923.
27. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov Disord 2011, 26:1049-1055.
28. Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011, 10:83-98.
29. Levitt J.J., Bobrow L., Lucia D., Srinivasan P. A selective review of volumetric and morphometric imaging in schizophrenia. Curr Top Behav Neurosci 2010, 4:243-281.
30. Waltz J.A., Frank M.J., Robinson B.M., Gold J.M. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biol Psychiatry 2007, 62:756-764.
31. Waltz J.A., Frank M.J., Wiecki T.V., Gold J.M. Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology 2011, 25:86-97.
32. Hoyle E., Genn R.F., Fernandes C., Stolerman I.P. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 2006, 189:211-223.
33. Young J.W., Crawford N., Kelly J.S., Kerr L.E., Marston H.M., Spratt C., et al. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 2007, 17:145-155.
34. Keller J.J., Keller A.B., Bowers B.J., Wehner J.M. Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task. Behav Brain Res 2005, 162:143-152.
35. Levin E.D., Petro A., Rezvani A.H., Pollard N., Christopher N.C., Strauss M., et al. Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav Brain Res 2009, 196:207-213.
36. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., et al. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 2004, 29:891-900.
37. Young J.W., Powell S.B., Geyer M.A., Jeste D.V., Risbrough V.B. The mouse attentional set-shifting task: A method for assaying successful cognitive aging?. Cogn Affect Behav Neurosci 2010, 10:243-251.
38. Eagle D.M., Humby T., Dunnett S.B., Robbins T.W. Effects of regional striatal lesions on motor, motivational, and executive aspects of progressive-ratio performance in rats. Behav Neurosci 1999, 113:718-731.
39. Young J.W., Geyer M.A. Action of Modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors?. Biol Psychiatry 2010, 67:784-787.
40. Young J.W., Meves J.M., Tarantino I.S., Caldwell S., Geyer M.A. Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice. Genes Brain Behav 2011, 10(7):720-733.
41. Cannon T.D., Keller M.C. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2006, 2:267-290.